Biomedical Engineering
Researchers offer proof-of-concept for altered nuclear transfer
Published in Gene Therapy Weekly, November 3rd, 2005
The theory, called altered nuclear transfer (ANT), proposes that researchers first create genetically altered embryos that are unable to implant in a uterus, and then extract stem cells from these embryos. Because the embryos cannot implant, they are by definition not "potential" human lives. Some suggest that this would quell the protests of critics who claim that embryonic stem cell research necessitates the destruction of human life. Scientists and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-11-03)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
MEOX2 homeobox gene reduction is linked to neurovascular dysfunction in mice - Biochemical Research
Adenovirus-mediated TPO gene transfer stimulates oval cell proliferation in liver - Infantile Neuronal Ceroid Lipofuscinosis
Intravitreal AAV-mediated gene therapy has direct benefits to the eye - Prostate Cancer
UCLA researchers identify how antibody blocks prostate cancer growth in animal models - Vaccine Development
Positive results of gene-based therapies for HIV, vascular disease published - Assisted Reproduction
Infertility researchers identify one gene's critical role in the human embryo implantation process - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
